Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -€0.22 Billion

According to Acceleron Pharma's latest financial reports the company's current earnings are €0.11 Billion. In 2020 the company made an earning of -€0.16 Billion a decrease over its 2019 earnings that were of -€0.13 Billion.

Earnings history for Acceleron Pharma from 2012 to 2021

Annual earnings

Year	Earnings	Change
2021 (TTM)	-€0.22 Billion	40.61%
2020	-€0.16 Billion	22.62%
2019	-€0.13 Billion	9.67%
2018	-€0.12 Billion	13.12%
2017	-€0.11 Billion	92.99%
2016	-€52.2 Million	-6.39%
2015	-€55.76 Million	20.95%
2014	-€46.1 Million	154.15%
2013	-€18.14 Million	-36.22%
2012	-€28.44 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Amgen AMGN	€4.22 B	-1,903.99%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	€4.37 B	-1,970.88%	🇺🇸 USA
Johnson & Johnson JNJ	€15.97 B	-6,926.91%	🇺🇸 USA
Onconova Therapeutics ONTX	-€16.63 Million	-92.89%	🇺🇸 USA
Sangamo Therapeutics SGMO	-€90.16 Million	-61.47%	🇺🇸 USA
bluebird bio BLUE	-€0.28 Billion	17.66%	🇺🇸 USA
Pfizer PFE	€10.17 B	-4,449.70%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Acceleron Pharma (XLRN)

Earnings in 2021 (TTM): -€0.22 Billion